Literature DB >> 3919826

Chronic hepatitis in the 1980s.

J Hegarty, R Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3919826      PMCID： PMC1417688          DOI： 10.1136/bmj.290.6472.877

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  15 in total

1.  Chronic hepatitis: reducing an iatrogenic enigma to a workable puzzle.

Authors:  H O Conn
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

2.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

3.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

4.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Authors:  R D Soloway; W H Summerskill; A H Baggenstoss; M G Geall; G L Gitnićk; I R Elveback; L J Schoenfield
Journal:  Gastroenterology       Date:  1972-11       Impact factor: 22.682

5.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

6.  Are the causes and presentation of chronic hepatitis changing? An analysis of 104 cases over 15 years.

Authors:  R A Bradbear; W N Robinson; W G Cooksley; J W Halliday; O D Harris; L W Powell
Journal:  Q J Med       Date:  1984

7.  Chronic active hepatitis: the spectrum of disease.

Authors:  J R Hodges; G H Millward-Sadler; R Wright
Journal:  Lancet       Date:  1982-03-06       Impact factor: 79.321

8.  Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.

Authors:  K C Lam; C L Lai; C Trepo; P C Wu
Journal:  N Engl J Med       Date:  1981-02-12       Impact factor: 91.245

9.  Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.

Authors:  G H Scullard; C I Smith; T C Merigan; W S Robinson; P B Gregory
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

10.  Chronic active hepatitis. Who meets treatment criteria?

Authors:  R L Koretz; K J Lewin; J Higgins; N D Fagen; G L Gitnick
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.